Skip to main content
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.390
+0.330 (10.78%)
At close: Mar 9, 2026, 4:00 PM EDT
3.310
-0.080 (-2.36%)
After-hours: Mar 9, 2026, 7:52 PM EDT

Aclaris Therapeutics Revenue

In the year 2025, Aclaris Therapeutics had annual revenue of $7.83M, down -58.19%. Aclaris Therapeutics had revenue of $1.30M in the quarter ending December 31, 2025, a decrease of -85.94%.

Revenue (ttm)
$7.83M
Revenue Growth
-58.19%
P/S Ratio
52.24
Revenue / Employee
$107,205
Employees
73
Market Cap
408.82M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20257.83M-10.89M-58.19%
Dec 31, 202418.72M-12.53M-40.09%
Dec 31, 202331.25M1.50M5.03%
Dec 31, 202229.75M22.99M340.05%
Dec 31, 20216.76M279.00K4.30%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ginkgo Bioworks Holdings 170.16M
Bicycle Therapeutics 28.34M
LENZ Therapeutics 17.50M
Armata Pharmaceuticals 5.05M
Absci 2.82M
Shattuck Labs 1.00M
Revenue Rankings

ACRS News

More News